Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Getting Onivyde (Irinotecan Liposome) Covered by Blue Cross Blue Shield in Georgia: A Complete Prior Authorization and Appeal Guide

Quick Answer: Blue Cross Blue Shield Georgia requires prior authorization for Onivyde (irinotecan liposome). Submit documentation showing metastatic pancreatic cancer, prior gemcitabine failure, ECOG 0-1 status, and proposed NALIRIFOX regimen. If denied, file internal appeal within 60 days, then external review through Georgia Department of Insurance within 60 days of

How to Get Evkeeza (Evinacumab-dgnb) Covered by Blue Cross Blue Shield in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Evkeeza Coverage Evkeeza (evinacumab-dgnb) requires prior authorization from Blue Cross Blue Shield in Georgia for patients with homozygous familial hypercholesterolemia (HoFH). Success depends on genetic confirmation, documented failure of standard therapies, and specialist involvement. If denied, you have 60 days to request external review through

How to Get Tremfya (guselkumab) Covered by Blue Cross Blue Shield in Washington: Prior Authorization Forms, Appeals, and Coding Guide

Quick Answer: Getting Tremfya Covered by Blue Cross Blue Shield in Washington Yes, Tremfya (guselkumab) can be covered by Blue Cross Blue Shield plans in Washington, but prior authorization is required. Most plans require step therapy with TNF inhibitors first, tuberculosis screening, and documentation of moderate-to-severe disease. If denied, Washington&

Work With Your Doctor to Get Procysbi Covered by Blue Cross Blue Shield in New York: Complete Guide

Answer Box: Getting Procysbi Covered in New York To get Procysbi (cysteamine bitartrate DR) covered by Blue Cross Blue Shield in New York: Your doctor must submit a prior authorization request with nephropathic cystinosis diagnosis confirmation (elevated WBC cystine levels), documentation of medical necessity, and evidence of step therapy completion

How to Get Kesimpta (Ofatumumab) Covered by Blue Cross Blue Shield in Ohio: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Kesimpta Covered in Ohio Blue Cross Blue Shield (BCBS) in Ohio requires prior authorization for Kesimpta (ofatumumab) with step therapy requirements. Most plans require documented failure or intolerance to at least one preferred disease-modifying therapy before approving Kesimpta for relapsing MS. Fastest path to approval: 1. Submit

How to Get Humira (Adalimumab) Covered by Blue Cross Blue Shield in Georgia: Complete Requirements Guide

Answer Box: Getting Humira Covered by BCBS Georgia To get Humira (adalimumab) covered by Blue Cross Blue Shield in Georgia, you must complete prior authorization and typically try preferred biosimilars first (step therapy). Submit the PA form with clinical documentation showing diagnosis, failed treatments, and medical necessity. If denied, file

How to Get Amondys 45 (Casimersen) Covered by Blue Cross Blue Shield in Georgia: Forms, Appeals, and Success Strategies

Answer Box: Getting Amondys 45 Covered in Georgia Blue Cross Blue Shield of Georgia requires prior authorization for Amondys 45 (casimersen) through their specialty pharmacy portal. The fastest path to approval: (1) Submit genetic testing proof showing DMD with exon 45 mutation via the Availity provider portal, (2) Include specialist

If Tavneos (Avacopan) Isn't Approved by Blue Cross Blue Shield in Ohio: Formulary Alternatives & Exception Paths

Answer Box: Quick Path Forward If Blue Cross Blue Shield Ohio denies Tavneos (avacopan) for ANCA vasculitis, you have covered alternatives. Rituximab and cyclophosphamide are typically formulary drugs with prior authorization. Start by requesting a formulary exception through your BCBS Ohio member portal within 72 hours if medically urgent. Document

How to Get Onpattro (Patisiran) Covered by Blue Cross Blue Shield in Virginia: Complete Coding, Appeals & Timeline Guide

Answer Box: Getting Onpattro Covered in Virginia Blue Cross Blue Shield (Anthem) in Virginia requires prior authorization for Onpattro (patisiran) under the medical benefit using HCPCS J0222. Success depends on proper coding (ICD-10 E85.1), genetic confirmation of TTR mutation, and neurologist evaluation. If denied, Virginia's State Corporation

Renewing Turalio (Pexidartinib) Approval with Blue Cross Blue Shield in North Carolina: Complete Timeline and Documentation Guide

Answer Box: Renewing Turalio Approval in North Carolina Blue Cross Blue Shield of North Carolina requires annual prior authorization renewal for Turalio (pexidartinib), typically 30-60 days before your current approval expires. You'll need updated TGCT diagnosis confirmation, proof of REMS program compliance with current liver function tests, and